The new discoveries of Basic Researchers: bile acids, oxygen radicals, intestinal glucose metabolism reprogramming, others? Gilles Mithieux « Nutrition.

Slides:



Advertisements
Similar presentations
The Surgical: proximal and distal intestine, partial removal of the stomach, ileal transposition, others Alper Çelik, M.D. Associate Professor of Surgery.
Advertisements

The endocrinological: insulin resistance-deficit secretion, incretins, intestinal hormones and microbiota Dr Alexander Miras NIHR Clinical Lecturer Diabetes.
Peter J Voshol, PhD Director of Disease Model Core Senior Research Associate: Integrative Physiology Disease Model Core Metabolic Phenotyping: which parameters.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
Weight Management Energy Balance Equation Balance: energy intake = energy expenditure energy intake > energy expenditure = weight gain energy intake.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Daniel Tat-ming Chung Princess Margaret Hospital 16 th April 2011 JHSGR.
“Developing and Nurturing a Career in GI Research” M. Michael Wolfe, M.D. Professor of Medicine Research Professor of Physiology and Biophysics Boston.
Journal Club 2009 年 1 月 29 日(木) 8 : 20 ~ 8 : 50 B 棟 8 階カンファレンスルーム 薬剤部 TTSP 石井 英俊.
Paper 3 Bariatric Surgery in Obese Rats. Regulation of Energy Balance Mainly controlled in the hypothalamus – Integration of hormonal and nutrient stimuli.
Metabolic disorders after Stroke Dr David Strain Peninsula Medical School Royal Devon & Exeter Hospital.
The role of GLP-1 in mediating the anorectic and metabolic effects of bariatric surgery. David D’Alessio, MD Division of Endocrinology University of Cincinnati.
Background Hyperglycemia has been reported in up to 80% of ELBW infants and is associated with increased morbidity and mortality. 1-3 Glucose instability.
Regulation of Blood Sugar Level at the Whole Animal Owen M c Guinness January 11, 2010 Course: MPB 333 Contact info: Phone: Office: 831C Light.
Obesity is a growing epidemic A disease of enormous proportions >65% adults are overweight >30% adults are obese in US (Ogden et al, 2006) Associated with.
MISS 2011 Physiology of Weight Regulation: Implications for Bariatric Surgery Lee M. Kaplan, MD, PhD Gastrointestinal Unit MGH Weight Center
 GLP-1 agonists have shown to help patients lose weight  Mechanism of GLP-1 agonists  Cardioprotective effects of GLP-1 agonists  GLP-1 agonists and.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Metabolic GI peptide hormones Ghrelin Insulin Glucagon Insulin Glucagon GIP GLP-1 Insulin Leptin Insulin Adiposity tissue insulin Insulin.
In the name of God.
Physiology of Hunger Glucose= blood sugar Glucose= blood sugar Pancreas produces insulin / breaks down glucose (converts some to stored fat) Pancreas produces.
Glucose Metabolism Dr Lenon T Gwaunza MBChB, BSc (Hons), MSc (UCL)
Hippocrates Prize Prof A. Kokkinos (Greece).
O.V. Grubnik, V.P. Golliak, V.V. Grubnik
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions?
Stages in the development of type 2 DM from a pre-diabetic, insulin-resistant state. As insulin sensitivity decreases, insulin-mediated glucose disposal.
Mechanisms of Action of the Bariatric Procedures
Obesity Dr. Sumbul Fatma.
From: Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes Ann Intern Med.

Choosing a test of glucose metabolism in mice.
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Volume 8, Issue 3, Pages (September 2008)
Volume 20, Issue 3, Pages (July 2017)
A Sweet Spot for the Bariatric Surgeon
David Bradley, Faidon Magkos, Samuel Klein  Gastroenterology 
Glucose homeostasis: roles of insulin and glucagon. 1A.
The Duodenum harbors a Broad Untapped Therapeutic Potential
Glucose homeostasis: roles of insulin, glucagon, amylin, and GLP-1.
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 141, Issue 3, Pages (September 2011)
Volume 11, Issue 4, Pages (April 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
GLP-1 Agonists and DPP-4 Inhibitors How do they work?
A whole body model for both glucose and fatty acid metabolism
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Volume 23, Issue 6, Pages (June 2016)
A brain-liver circuit regulates glucose homeostasis
Volume 8, Issue 4, Pages (October 2008)
A Sweet Spot for the Bariatric Surgeon
Volume 5, Issue 6, Pages (June 2007)
Hyperinsulinemic-euglycemic clamps revealed that obese TPL2KO mice have an improved insulin sensitivity compared with obese WT mice. Hyperinsulinemic-euglycemic.
Effect of metformin on glycemic control, insulin secretion, and insulin sensitivity in T2D. Effect of metformin on glycemic control, insulin secretion,
Plasma glucose (A) and glucose specific activity (B) during euglycemic clamp experiments. Plasma glucose (A) and glucose specific activity (B) during euglycemic.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
Transgenic restoration of long-chain n-3 PUFA protects against obesity-linked insulin resistance and glucose intolerance. Transgenic restoration of long-chain.
Fig. 2 HHKO mice exhibit improved glucose tolerance by increasing plasma incretin levels and insulin secretion. HHKO mice exhibit improved glucose tolerance.
ATL-801 treatment increases insulin sensitivity in KKAY mice.
Rapid improvement of glucose tolerance induced by PP
USP2–45 regulates hepatic gluconeogenesis.
Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.
Metabolic effects of VSG in GLP-1r KO mice.
Gut-Brain Glucose Signaling in Energy Homeostasis
Pathophysiology and drug targets.
Spearman rank order correlation between suppression of hepatic glucose production with low insulin infusion and 30-min change in glucose response in women.
Volume 26, Issue 2, Pages e3 (January 2019)
(A and B) Correlation graphs of changes between weeks 0 and 2 in relevant clinical variables and faecal microbiota operational taxonomic unit (OTUs) for.
Evidence against a Physiologic Role for Acute Changes in CNS Insulin Action in the Rapid Regulation of Hepatic Glucose Production  Christopher J. Ramnanan,
Presentation transcript:

The new discoveries of Basic Researchers: bile acids, oxygen radicals, intestinal glucose metabolism reprogramming, others? Gilles Mithieux « Nutrition and Brain » Inserm U855, university of Lyon, France

CONTROL OF GLYCEMIA Insulin glucose Endogenous Glucose Production liverIntestinekidney

Glucose-6 phosphatase : the key enzyme of EGP

EVIDENCE for its EXPRESSION In the INTESTINAL MUCOSA Gastroenterology, 1999

PRODUCTION OF GLUCOSE – FASTING Normal state  15%  80%  5% Fasting state  20%  45%  35% G6PC PEPCK Diabetes, 2001

WHAT’S HAPPENING IN THE DIABETIC STATE ?

CONTROL OF GLYCEMIA - DIABETES Insulin glucose Endogenous Glucose Production liverIntestinekidney

normal diabetic Insulin tolerance test

2) This results in glucose intolerance Time (mn) % basal glucose ** normal diabetic glucose tolerance test

3) Endogenous glucose production is increased 1) Peripheral glucose utilization is decreased 4) End-point: fasting plasma glucose is increased, when insulin secretion becomes insufficient to compensate insulin resistance 2) Insulin secretion is increased, partly compensating insulin resistance A probable sequence of events is:

WHAT ARE THE MODIFICATIONS OBSERVED AFTER OBESITY SURGERY? especially after bypass procedures…

In morbid obese: - marked decrease in appetite (hunger sensations) - modifications of liking for some foods In diabetic obese: - dramatic and rapid amelioration of diabetes

The rationale the most often put forward to account for this amelioration is based on the restoration of postprandial secretion of incretin hormones (e.g.GLP-1), promoting a restored secretion of insulin.

Ileum Duodenum Esophagus Proximal Jejunum Stomach Distal Jejunum Ileum Esophagus Proximal Jejunum Stomach Distal Jejunum bandingbypass = EGA What’s happening in obese diabetic mice (HF-HS diet) ? restrictive procedure malabsorptive procedure

The differential efficiency of the various gastric surgeries is an early event

Pair-fed sham band EGA Days Food intake (g/d) Surgery Daily food intake Days Body weight (g) Surgery Body weight on pair-feeding Decreased food intake No malabsorption EGA Band

Time (mn) Pair-fed shamGLBEGA A Time (m n) % basal glucose * * $ $ glucose tolerance Insulin secretion EGA

SDHFDPair-fed sham GBEGA GLP-1 (pmol/l) T0 T40 $ # § * GLP-1 plasma levels during OGTT

Time (mn) % basal glucose § § § ITT Pair-fed shamEGA There is also a marked increase in insulin sensitivity after bypass EGA

Which is the function improved in terms of insulin sensitivity after bypass? EGP of peripheral glucose utilization?

sham mg/kg/mn Glucose infusion rate (GIR) Endogenous Glucose Production (EGP) Peripheral glucose utilization (Rd) SDHFDPair-fedGLBEGA * * * § $ $ $ Euglycemic hyperinsulinemic clamps reveals improved suppression of EGP by insulin, and no effect on glucose utilization

CONTROL OF GLYCEMIA - DIABETES Insulin glucose Endogenous Glucose Production liverIntestinekidney

HFD Sham GLBEGA Segment n°4 G6Pase (arbitrary units) * G6Pase actin HFD Sham GLBEGA Segment n°4 * actin PEPCK PEPCK (arbitrary units) Segment n° HFDSham GLBEGA G6Pase activity (µmol/min/g) * HFDSham GLBEGA Segment n°3 G6Pase activity (µmol/min/g) * HFDSham GLBEGA Segment n°4 G6Pase activity (µmol/min/g) Ileum Duodenum Esophagus Proximal Jejunum Stomach Distal Jejunum

HFDPair-fed shamGLB EGA Micromole / min/g NS $ * Hepatic G6Pase activity

PRODUCTION OF GLUCOSE – BYPASS Before surgery  5% After bypass  15-20%  45%  35%  15-20%  80%  50%  30%

Early after bypass in mice: there is a dramatic change in whole body glucose metabolism - recovery of insulin sensitivity (of EGP) - recovery of pancreatic function (GLP-1and insulin secretions) - amelioration of glucose tolerance - no change in basal EGP, but a new repartition among the 3 gluconeogenic organs, with an increased participation of the gut

Hayes et al, OBES SURG (2011) 21:759–762 Is Intestinal Gluconeogenesis a Key Factor in the Early Changes in Glucose homeostasis following Gastric Bypass?